Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of specialty healthcare in India focused on cancer and fertility.
HCG operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed. HCG also operates fertility centers under the ‘Milann’ brand.
As of December 31, 2015, HCG network consisted of 14 comprehensive cancer centers, including center of excellence in Bengaluru, three freestanding diagnostic centers and one day care chemotherapy center across India.
Under Triesta brand, HCG provide clinical reference laboratory services in India with a specialization in oncology, including molecular diagnostic services and genomic testing. Triesta central reference laboratory is located in center of excellence in Bengaluru.
Strengths of the Company:
- Largest provider of cancer care in India with a proven track record
- High quality cancer care provided at a competitive price
- Entry into high potential fertility business
- Strong management team with successful track record
- Highly skilled specialist physicians
- ‘hub and spoke’ business model and partnership arrangements
Healthcare Global IPO Details
| IPO Opening Date | 16-Mar-16 |
| IPO Closing Date | 18-Mar-16 |
| Issue Type | Book Built Issue IPO |
| Face Value | ₹10 per equity share |
| IPO Price | ₹205 to ₹218 per equity share |
| Market Lot | 65 Shares |
| Min Order Quantity | 65 Shares |
| Listing At | BSE, NSE |
| Issue Size | 29,800,000 Eq Shares of ₹10 (aggregating up to ₹649.64 Cr) |
Company Promoters:
Dr. BS Ajani Kumar, Dr. KS Gopinath, Dr. Ganesh Nayak, Dr. M Gopichand and Dr. BS Ramesh are the Promoters of the Company.
Company Financials:
| Particular | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | 31-Mar-11 |
| Total Liabilities | 6,895.42 | 6,138.21 | 6,436.40 | 4,362.63 | 3,203.63 |
| Total Assets | 6,895.42 | 6,138.21 | 6,436.40 | 4,362.63 | 3,203.63 |
| Total Revenue | 4,244.41 | 3,525.94 | 2,939.52 | 2,051.67 | 1,601.43 |
| Profit After Tax (PAT) | -23.66 | -394.98 | -71.58 | -40.02 | 34.4 |
Objects of the Issue:
The Offer comprises of Fresh Issue and the Offer for Sale.
Offer for Sale
Company will not receive any proceeds from the Offer for Sale.
Fresh Issue
Company proposes to utilise the Net Proceeds towards funding the following objects:
- Purchase of medical equipment;
- Investment in IT software, services and hardware;
- Pre-payment of debt; and
- General corporate purposes.
Healthcare Global IPO Lot Size
The Healthcare Global IPO market lot size is 65 shares. A retail-individual investor can apply for up to 14 lots (910 shares or ₹198,380).
| Application | Lots | Shares | Amount (Cut-off) |
| Minimum | 1 | 65 | (65*218)=₹14,170 |
| Maximum | 14 | 910 | (910*218)₹198,380 |
HCG IPO Time Table
| Particular | Date |
| Opening Date | 16-Mar-16 |
| Closing Date | 18-Mar-16 |
| Allotment Date | |
| Refund Date | |
| Listing Date | 30 March 2016 |
| Healthcare Global IPO Registrar KFintech Private Limited Selenium Building, Tower-B, Plot No 31 & 32, Financial District,Nanakramguda, Serilingampally, Rangareddi, Telangana India – 500 032. Phone: 1-800-3454001 Email: einward.ris@karvy.com Website: https://karisma.kfintech.com/ | Company Contact Information Healthcare Global Enterprises Ltd HCG Tower, No. 8, P Kalinga Rao Road, Sampangi Rama Nagar, Bengaluru 560 027 Phone: +91 80 4660 7700 Email: investors@hcgoncology.com Website: http://www.hcgel.com |
